Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Revenue

Kangmei Pharmaceutical had revenue of 1.24B CNY in the quarter ending September 30, 2026, a decrease of -10.51%. This brings the company's total for the last twelve months to 4.82B, down -8.63% year-over-year. In the year 2025, Kangmei Pharmaceutical had annual revenue of 5.25B with 1.22% growth. That makes Kangmei Pharmaceutical the 9,223rd largest company in the world by revenue and 1,470th in China.

• Revenue (ttm): 4.82B
• Revenue Growth: -8.63%
• P/S Ratio: 3.67
• Revenue / Employee: 877.65K
• Employees: 5,492
• Market Cap: 17.70B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Traditional Chinese Medicine, Western Medicine and Medical Devices 4.22B 80.3%
• Property Leasing and Sales and Others 532.62M 10.1%
• Health Food and Food 500.27M 9.5%

Fiscal year ended Dec 31, 2025 See the full Kangmei Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.25B	63.08M	1.22%
Dec 31, 2024	5.19B	315.12M	6.47%
Dec 31, 2023	4.87B	693.87M	16.60%
Dec 31, 2022	4.18B	27.63M	0.67%
Dec 31, 2021	4.15B	-1.26B	-23.27%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error